NewslettersImmune Regulation NewsUncategorizedA TNFR2 Antibody by Countering Immunosuppression Cooperates with HMGN1 and R848 Immune Stimulants to Inhibit Murine Colon CancerBy Justin.choi - November 19, 20210252Scientists examined the efficacy of TY101 as an anti-tumor immune reagent combined with HMGN1and R848.[International Immunopharmacology] 6445212 AAAAAAAA items 1 apa 0 default asc 1 169114 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract